JBIO vs HROW
Comparison between Jade Biosciences Inc (JBIO, Company) and Harrow Inc (HROW, Company).
Both JBIO and HROW are from the Healthcare sector.
5-Year PerformanceHROW has outperformed JBIO, delivering a return of +33.9% compared to -41.7%
JBIO vs HROW - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
JBIO vs HROW - Historical Returns
Returns include dividend reinvestment.
JBIO vs HROW - Annual Returns (2007 - 2026)
Returns include dividend reinvestment.
| Year | JBIO | HROW |
|---|---|---|
| 2026 | +68.15% | -22.12% |
| 2025 | -79.69% | +34.03% |
| 2024 | -87.85% | +180.75% |
| 2023 | -16.28% | -24.22% |
| 2022 | +168.07% | +70.44% |
| 2021 | -48.36% | +17.55% |
| 2020 | N/A | -6.03% |
| 2019 | N/A | +51.07% |
| 2018 | N/A | +228.90% |
| 2017 | N/A | -31.17% |
| 2016 | N/A | -63.24% |
| 2015 | N/A | -8.09% |
| 2014 | N/A | +107.76% |
| 2013 | N/A | -61.60% |
| 2012 | N/A | +204.69% |
| 2011 | N/A | -84.81% |
| 2010 | N/A | -45.52% |
| 2009 | N/A | +50.00% |
| 2008 | N/A | -63.64% |
| 2007 | N/A | -8.33% |
JBIO vs HROW Drawdown Comparison
The maximum drawdown for JBIO was -99.22%, occurring on Jun 13, 2025. This drawdown has not yet recovered.
The maximum drawdown for HROW was -99.46%, occurring on Mar 19, 2012. This drawdown has not yet recovered.
The current JBIO drawdown is -97.26%. The current HROW drawdown is -71.83%.
| Rank | JBIO | HROW |
|---|---|---|
| #1 | -99.22% Apr 1, 2024 - Jun 13, 2025 | -99.46% Oct 4, 2007 - Mar 19, 2012 |
| #2 | -68.61% Dec 12, 2022 - Apr 1, 2024 | N/A |
| #3 | -63.86% Jun 30, 2021 - Aug 1, 2022 | N/A |
| #4 | -42.73% Aug 12, 2022 - Dec 12, 2022 | N/A |
| #5 | -4.56% Aug 5, 2022 - Aug 12, 2022 | N/A |
Correlation
Correlation between JBIO and HROW is -0.79 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks